Page last updated: 2024-12-08
1-deoxyglucosamine
Description
## 1-Deoxyglucosamine: A Key Player in Glycosylation and Research
1-deoxyglucosamine (1-DG) is a modified sugar molecule that lacks the hydroxyl group at the C1 position, a crucial difference compared to glucosamine. This seemingly small change has significant implications for its biological function and research value.
**Here's what makes 1-deoxyglucosamine important for research:**
* **Glycosylation inhibitor:** 1-DG is a potent inhibitor of glycosylation, a process that adds sugar molecules to proteins and lipids. This inhibition is particularly impactful for N-linked glycosylation, where sugars are added to the asparagine residues of proteins. This property makes 1-DG a valuable tool to study the role of glycosylation in various cellular processes.
* **Cancer research:** 1-DG has shown promise in cancer research. It can block the growth of cancerous cells by inhibiting their glycosylation, thus impacting their signaling and adhesion processes. Researchers are exploring its potential as a therapeutic agent for various cancers.
* **Inflammatory disease research:** 1-DG has demonstrated anti-inflammatory effects in preclinical studies. Its ability to modulate glycosylation pathways could be beneficial in managing inflammatory conditions like arthritis and Crohn's disease.
* **Neuropathology research:** 1-DG's influence on glycosylation has attracted attention in neurodegenerative diseases like Alzheimer's disease and Parkinson's disease. Researchers are investigating its role in managing the accumulation of misfolded proteins that contribute to these conditions.
* **Metabolic research:** 1-DG's ability to interfere with glycosylation processes makes it a tool to study metabolic pathways involving sugar utilization and storage. This research can potentially lead to a better understanding of diabetes and obesity.
* **Drug development:** 1-DG's unique chemical structure and its biological activity make it a promising candidate for the development of new drugs targeting glycosylation processes.
**It's important to note that:**
* 1-DG research is still in its early stages, and further investigation is needed to fully understand its potential applications and safety profile.
* More research is necessary to determine the precise mechanisms of action and the specific pathways affected by 1-DG in different biological contexts.
Overall, 1-deoxyglucosamine is a fascinating molecule with considerable potential in diverse research fields. Its ability to interfere with glycosylation opens up avenues for understanding complex cellular processes and developing novel therapeutic strategies for various diseases.
1-deoxyglucosamine: RN given refers to parent cpd (D)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 169430 |
SCHEMBL ID | 10108131 |
MeSH ID | M0136435 |
Synonyms (10)
Synonym |
1-deoxyglucosamine |
32449-61-9 |
2-amino-1,5-anhydro-2-deoxy-d-glucitol |
(2r,3s,4r,5s)-5-amino-2-(hydroxymethyl)oxane-3,4-diol |
d-glucitol, 2-amino-1,5-anhydro-2-deoxy- |
SCHEMBL10108131 |
1-deoxy-d-glucosamine |
2-deoxyglucosamine |
2-amino-1,5-anhydro-2-deoxyhexitol |
DTXSID50954201 |
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 4 (66.67) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.41
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.41 (24.57) | Research Supply Index | 1.95 (2.92) | Research Growth Index | 4.36 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |